Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19
Public ClinicalTrials.gov record NCT04351152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Placebo-Controlled Study of Lenzilumab in Hospitalized Patients With Severe and Critical COVID-19 Pneumonia
Study identification
- NCT ID
- NCT04351152
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Humanigen, Inc.
- Industry
- Enrollment
- 520 participants
Conditions and interventions
Interventions
- Lenzilumab Biological
- Standard of Care Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2020
- Primary completion
- Feb 28, 2021
- Completion
- Feb 28, 2021
- Last update posted
- Mar 2, 2021
2020 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 | — |
| University of California, Irvine | Irvine | California | 92697 | — |
| University of Southern California (USC) Medical Center | Los Angeles | California | 90033 | — |
| USC - Los Angeles County Medical Center | Los Angeles | California | 90033 | — |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Mayo Clinic | Jacksonville | Florida | 32216 | — |
| AdventHealth Orlando | Orlando | Florida | 32803 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| St. Elizabeth Healthcare | Edgewood | Kentucky | 41017 | — |
| Hennepin County Medical Center | Minneapolis | Minnesota | 55415 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Dartmouth-Hitchcock | Lebanon | New Hampshire | 03756 | — |
| Saint Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| Mercy Medical Center | Rockville Centre | New York | 11570 | — |
| Atrium Health | Charlotte | North Carolina | 28203 | — |
| St. David's Healthcare | Austin | Texas | 78705 | — |
| St. David's North Austin Medical Center | Austin | Texas | 78758 | — |
| Texas Health | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04351152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04351152 live on ClinicalTrials.gov.